Canada In Vitro Diagnostics Investment Opportunities Analysis and Forecasts to 2012:

Canada In Vitro Diagnostics Investment Opportunities Analysis and Forecasts to 2012

Published Date: September 2008

Published By: Global Markets Direct

Page Count: 138

Order Code: R3480-6220

Questions About This Report

E-mail a Colleague

Printable Page

Fax Your Order

Description

Table of Contents

Similar
Products

1 Table Of Contents: 1.1 List of Tables; 1.2 List of Figures
2 Introduction: 2.1 What Is This Report About?
3 Definitions of Markets Covered in the Report: 3.1 In Vitro Diagnostics Devices; 3.2 Clinical Chemistry Test Reagents; 3.3 Immunochemistry Test Reagents; 3.4 Blood Test Reagents; 3.5 Microbiology Test Reagents; 3.6 Infectious Immunology Test Reagents; 3.7 Genetic Test Reagents; 3.8 Self Testing; 3.9 Instruments
4 Healthcare Sector Review: 4.1 Healthcare Expenditure; 4.2 Healthcare Infrastructure; 4.3 Healthcare Policy; 4.4 Canada Healthcare Trade Statistics
5 Regulation System: 5.1 Medical Equipment Approval Process; 5.2 Labeling and Packaging; 5.3 Post-Market Surveillance
6 Pricing and Reimbursement
7 Distribution Structure: 7.1 Distribution Structure
8 Canada Medical Equipment Cross Market Comparison
9 In Vitro Diagnostics In Canada: 9.1 In Vitro Diagnostics Cross Country Comparison (2000-2012); 9.2 In Vitro Diagnostics, Canada, Overall Revenues, 2000-2012; 9.3 In Vitro Diagnostics, Canada, Company Share (2006-2007)
10 Blood Test Reagents In Canada: 10.1 Blood Test Reagents Overall Revenue (2000-2012); 10.2 Blood Test Reagents Distribution Share (2006-2007); 10.3 Blood Test Reagents, Canada, Company Share (2006-2007)
11 Clinical Chemistry Test Reagents In Canada: 11.1 Clinical Chemistry Test Reagents Overall Revenue (2000-2012); 11.2 Clinical Chemistry Test Reagents Distribution Share (2006-2007); 11.3 Clinical Chemistry Test Reagents, Canada, Company Share (2006-2007)
12 Genetic Test Reagents In Canada: 12.1 Genetic Test Reagents Overall Revenue (2000-2012); 12.2 Genetic Test Reagents Distribution Share (2006-2007); 12.3 Genetic Test Reagents, Canada, Company Share (2006-2007)
13 Immunochemistry Test Reagents In Canada: 13.1 Immunochemistry Test Reagents Overall Revenue (2000-2012); 13.2 Immunochemistry Test Reagents Distribution Share (2006-2007); 13.3 Immunochemistry Test Reagents, Canada, Company Share (2006-2007)
14 Infectious Immunology Test Reagents In Canada: 14.1 Infectious Immunology Test Reagents Overall Revenue (2000-2012); 14.2 Infectious Immunology Test Reagents Distribution Share (2006-2007); 14.3 Infectious Immunology Test Reagents, Canada, Company Share (2006-2007)
15 Instruments In Canada: 15.1 Instruments Overall Revenue (2000-2012); 15.2 Instruments Distribution Share (2006-2007); 15.3 Instruments, Canada, Company Share (2006-2007)
16 Microbiology Test Reagents In Canada: 16.1 Microbiology Test Reagents Overall Revenue (2000-2012); 16.2 Microbiology Test Reagents Distribution Share (2006-2007); 16.3 Microbiology Test Reagents, Canada, Company Share (2006-2007)
17 Self Testing In Canada: 17.1 Self Testing Overall Revenue (2000-2012); 17.2 Self Testing Distribution Share (2006-2007); 17.3 Self Testing, Canada, Company Share (2006-2007)
18 F. Hoffmann-La Roche Ltd. Company Profile: 18.1 Company Overview; 18.2 Value Chain Analysis
19 Beckman Coulter, Inc. Company Profile: 19.1 Company Overview; 19.2 Value Chain Analysis; 19.3 Beckman Coulter, Inc. Pipeline Products
20 Dade Behring Holdings, Inc. Company Profile: 20.1 Company Overview; 20.2 Dade Behring Holdings, Inc. Pipeline Products
21 Abbott Laboratories Company Profile: 21.1 Company Overview; 21.2 Value Chain Analysis; 21.3 Abbott Laboratories Pipeline Products
22 Siemens Medical Solutions Company Profile: 22.1 Company Overview; 22.2 Value Chain Analysis; 22.3 Siemens Medical Solutions Pipeline Products
23 bioMerieux S.A. Company Profile: 23.1 Company Overview; 23.2 Value Chain Analysis
24 Affinity Biologicals Incorporated Company Profile: 24.1 Company Overview
25 Biocore Systems Inc. Company Profile: 25.1 Company Overview
26 bioLytical Laboratories Inc. Company Profile: 26.1 Company Overview; 26.2 bioLytical Laboratories Inc. Pipeline Products
27 Biomedica Diagnostics Inc. Company Profile: 27.1 Company Overview
28 Cedarlane Laboratories Limited Company Profile: 28.1 Company Overview
29 Diagnostics Chemicals Limited Company Profile: 29.1 Company Overview
30 DRAXIMAGE Company Profile: 30.1 Company Overview
31 Medicorp Inc. Company Profile: 31.1 Company Overview
32 Medmira Inc. Company Profile: 32.1 Company Overview
33 Financial Deals Landscape: 33.1 Acquisition; 33.2 Venture Financing
34 Recent Developments: 34.1 Strategy and Business Planning
35 APPENDIX: 35.1 Global Markets Direct Research Methodology; 35.2 Coverage; 35.3 Secondary Research; 35.4 Primary Research; 35.5 Models; 35.6 Forecasts; 35.7 Expert Panels; 35.8 Currency Conversion; 35.9 Contact Us; 35.10 Disclaimer
1.1 List of Tables: Table 1: Number of Physicians by Province in Canada, 2001 and 2005; Table 2: Hospital Wards by Specialty in Canada, 2003-2007; Table 3: Doctors by Specialty in Canada, 2003-2007; Table 4: Canada Healthcare Trade Statistics, 2001-2006; Table 5: Medical Equipment Classification in Canada, 2007; Table 6: Medical Equipment Licensing Fee in Canada, 2007; Table 7: Medical Equipment License Processing Duration in Canada, 2007; Table 8: Canada, Medical Equipment Market Comparison; Table 9: In Vitro Diagnostics Cross Country Comparison (2000-2012); Table 10: In Vitro Diagnostics, Canada, Overall Revenues ($ mn), 2000-2012; Table 11: In Vitro Diagnostics Market, Canada, Portfolio Analysis; Table 12: In Vitro Diagnostics, Canada, Overall Revenues ($ mn), Historic, 2000-2007; Table 13: In Vitro Diagnostics, Canada, Overall Revenues ($ mn), Forecast, 2007-2012; Table 14: In Vitro Diagnostics, Canada, Company Share by Revenue ($ mn), 2006-2007; Table 15: Blood Test Reagents, Canada, Revenue ($ mn) by Segment, Historic, 2000-2007; Table 16: Blood Test Reagents, Canada, Revenue ($ mn) by Segment, Forecast, 2007-2012; Table 17: Haematology Test Reagents, Canada, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007; Table 18: Haematology Test Reagents, Canada, Revenues ($ mn) by Sub-Segment, Forecast,, 2007-2012; Table 19: Hemostasis Test Reagents, Canada, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007; Table 20: Hemostasis Test Reagents, Canada, Revenues ($ mn) by Sub-Segment, Forecast,, 2007-2012; Table 21: Blood Test Reagents, Canada, Distribution Share by Revenue ($ mn), 2006-2007; Table 22: Blood Test Reagents, Canada, Company Share by Revenue ($ mn), 2006-2007; Table 23: Clinical Chemistry Test Reagents, Canada, Revenue ($ mn) by Segment, Historic, 2000-2007; Table 24: Clinical Chemistry Test Reagents, Canada, Revenue ($ mn) by Segment, Forecast, 2007-2012; Table 25: Clinical Chemistry Test Reagents, Canada, Distribution Share by Revenue ($ mn), 2006-2007; Table 26: Clinical Chemistry Test Reagents, Canada, Company Share by Revenue ($ mn), 2006-2007; Table 27: Genetic Test Reagents, Canada, Revenue ($ mn) by Segment, Historic, 2000-2007; Table 28: Genetic Test Reagents, Canada, Revenue ($ mn) by Segment, Forecast, 2007-2012; Table 29: Genetic Test Reagents, Canada, Distribution Share by Revenue ($ mn), 2006-2007; Table 30: Genetic Test Reagents, Canada, Company Share by Revenue ($ mn), 2006-2007; Table 31: Immunochemistry Test Reagents, Canada, Revenue ($ mn) by Segment, Historic, 2000-2007; Table 32: Immunochemistry Test Reagents, Canada, Revenue ($ mn) by Segment, Forecast, 2007-2012; Table 33: Disease Specific Markers, Canada, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007; Table 34: Disease Specific Markers, Canada, Revenues ($ mn) by Sub-Segment, Forecast,, 2007-2012; Table 35: Disease Specific Test Reagents, Canada, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007; Table 36: Disease Specific Test Reagents, Canada, Revenues ($ mn) by Sub-Segment, Forecast,, 2007-2012; Table 37: Drug Related Testing Reagents, Canada, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007; Table 38: Drug Related Testing Reagents, Canada, Revenues ($ mn) by Sub-Segment, Forecast,, 2007-2012; Table 39: Hormone Related Testing Reagents, Canada, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007; Table 40: Hormone Related Testing Reagents, Canada, Revenues ($ mn) by Sub-Segment, Forecast,, 2007-2012; Table 41: Immunochemistry Test Reagents, Canada, Distribution Share by Revenue ($ mn), 2006-2007; Table 42: Immunochemistry Test Reagents, Canada, Company Share by Revenue ($ mn), 2006-2007; Table 43: Infectious Immunology Test Reagents, Canada, Revenue ($ mn) by Segment, Historic, 2000-2007; Table 44: Infectious Immunology Test Reagents, Canada, Revenue ($ mn) by Segment, Forecast, 2007-2012; Table 45: Virology, Canada, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007; Table 46: Virology, Canada, Revenues ($ mn) by Sub-Segment, Forecast,, 2007-2012; Table 47: Infectious Immunology Test Reagents, Canada, Distribution Share by Revenue ($ mn), 2006-2007; Table 48: Infectious Immunology Test Reagents, Canada, Company Share by Revenue ($ mn), 2006-2007; Table 49: Instruments, Canada, Revenue ($ mn) by Segment, Historic, 2000-2007; Table 50: Instruments, Canada, Revenue ($ mn) by Segment, Forecast, 2007-2012; Table 51: Instruments, Canada, Distribution Share by Revenue ($ mn), 2006-2007; Table 52: Instruments, Canada, Company Share by Revenue ($ mn), 2006-2007; Table 53: Microbiology Test Reagents, Canada, Revenue ($ mn) by Segment, Historic, 2000-2007; Table 54: Microbiology Test Reagents, Canada, Revenue ($ mn) by Segment, Forecast, 2007-2012; Table 55: Bacteriology Test Reagents, Canada, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007; Table 56: Bacteriology Test Reagents, Canada, Revenues ($ mn) by Sub-Segment, Forecast,, 2007-2012; Table 57: Microbiology Test Reagents, Canada, Distribution Share by Revenue ($ mn), 2006-2007; Table 58: Microbiology Test Reagents, Canada, Company Share by Revenue ($ mn), 2006-2007; Table 59: Self Testing, Canada, Revenue ($ mn) by Segment, Historic, 2000-2007; Table 60: Self Testing, Canada, Revenue ($ mn) by Segment, Forecast, 2007-2012; Table 61: Self Testing, Canada, Distribution Share by Revenue ($ mn), 2006-2007; Table 62: Self Testing, Canada, Company Share by Revenue ($ mn), 2006-2007; Table 63: Beckman Coulter, Inc. Pipeline Products by Equipment Type; Table 64: Beckman Coulter, Inc. Pipeline Products By Development Stage; Table 65: Beckman Coulter, Inc. Pipeline Products By Therapy Area; Table 66: Beckman Coulter, Inc. Pipeline Products By News Summaries; Table 67: Dade Behring Holdings, Inc. Pipeline Products by Equipment Type; Table 68: Dade Behring Holdings, Inc. Pipeline Products By Development Stage; Table 69: Dade Behring Holdings, Inc. Pipeline Products By Therapy Area; Table 70: Dade Behring Holdings, Inc. Pipeline Products By News Summaries; Table 71: Abbott Laboratories Pipeline Products by Equipment Type; Table 72: Abbott Laboratories Pipeline Products By Development Stage; Table 73: Abbott Laboratories Pipeline Products By Therapy Area; Table 74: Abbott Laboratories Pipeline Products By Clinical Trials; Table 75: Abbott Laboratories Pipeline Products By News Summaries; Table 76: Siemens Medical Solutions Pipeline Products by Equipment Type; Table 77: Siemens Medical Solutions Pipeline Products By Development Stage; Table 78: Siemens Medical Solutions Pipeline Products By Therapy Area; Table 79: Siemens Medical Solutions Pipeline Products By News Summaries; Table 80: bioLytical Laboratories Inc. Pipeline Products by Equipment Type; Table 81: bioLytical Laboratories Inc. Pipeline Products By Development Stage; Table 82: bioLytical Laboratories Inc. Pipeline Products By Therapy Area; Table 83: bioLytical Laboratories Inc. Pipeline Products By Clinical Trials; Table 84: bioLytical Laboratories Inc. Pipeline Products By News Summaries; Table 85: Currency Conversion from USD to Local Currency at 2007 Constant Rate
1.2 List of Figures: Figure 1: Healthcare Financing in Canada, 2004; Figure 2: Healthcare Expenditure in Canada, 2000 - 2006; Figure 3: Canada, Medical Equipment Market Comparison,2007; Figure 4: In Vitro Diagnostics Cross Country Comparison (2000-2012); Figure 5: In Vitro Diagnostics, Canada, Overall Revenues ($ mn), 2000-2012; Figure 6: In Vitro Diagnostics Market, Canada, Portfolio Analysis; Figure 7: In Vitro Diagnostics, Canada, Overall Revenues ($ mn), Historic, 2000-2007; Figure 8: In Vitro Diagnostics, Canada, Overall Revenues ($ mn), Forecast, 2007-2012; Figure 9: In Vitro Diagnostics, Canada, Company Share (%), 2007; Figure 10: Blood Test Reagents, Canada, Revenue ($ mn) by Segment, Historic, 2000-2007; Figure 11: Blood Test Reagents, Canada, Revenue ($ mn) by Segment, Forecast, 2007-2012; Figure 12: Haematology Test Reagents, Canada, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007; Figure 13: Haematology Test Reagents, Canada, Revenues ($ mn) by Sub-Segment, Forecast,, 2007-2012; Figure 14: Hemostasis Test Reagents, Canada, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007; Figure 15: Hemostasis Test Reagents, Canada, Revenues ($ mn) by Sub-Segment, Forecast,, 2007-2012; Figure 16: Blood Test Reagents, Canada, Company Share (%), 2007; Figure 17: Clinical Chemistry Test Reagents, Canada, Revenue ($ mn) by Segment, Historic, 2000-2007; Figure 18: Clinical Chemistry Test Reagents, Canada, Revenue ($ mn) by Segment, Forecast, 2007-2012; Figure 19: Clinical Chemistry Test Reagents, Canada, Company Share (%), 2007; Figure 20: Genetic Test Reagents, Canada, Revenue ($ mn) by Segment, Historic, 2000-2007; Figure 21: Genetic Test Reagents, Canada, Revenue ($ mn) by Segment, Forecast, 2007-2012; Figure 22: Genetic Test Reagents, Canada, Company Share (%), 2007; Figure 23: Immunochemistry Test Reagents, Canada, Revenue ($ mn) by Segment, Historic, 2000-2007; Figure 24: Immunochemistry Test Reagents, Canada, Revenue ($ mn) by Segment, Forecast, 2007-2012; Figure 25: Disease Specific Markers, Canada, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007; Figure 26: Disease Specific Markers, Canada, Revenues ($ mn) by Sub-Segment, Forecast,, 2007-2012; Figure 27: Disease Specific Test Reagents, Canada, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007; Figure 28: Disease Specific Test Reagents, Canada, Revenues ($ mn) by Sub-Segment, Forecast,, 2007-2012; Figure 29: Drug Related Testing Reagents, Canada, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007; Figure 30: Drug Related Testing Reagents, Canada, Revenues ($ mn) by Sub-Segment, Forecast,, 2007-2012; Figure 31: Hormone Related Testing Reagents, Canada, Revenues ($ mn) by Sub-Segment, Forecast,, 2007-2012; Figure 32: Immunochemistry Test Reagents, Canada, Company Share (%), 2007; Figure 33: Infectious Immunology Test Reagents, Canada, Revenue ($ mn) by Segment, Historic, 2000-2007; Figure 34: Infectious Immunology Test Reagents, Canada, Revenue ($ mn) by Segment, Forecast, 2007-2012; Figure 35: Virology, Canada, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007; Figure 36: Virology, Canada, Revenues ($ mn) by Sub-Segment, Forecast,, 2007-2012; Figure 37: Infectious Immunology Test Reagents, Canada, Company Share (%), 2007; Figure 38: Instruments, Canada, Revenue ($ mn) by Segment, Historic, 2000-2007; Figure 39: Instruments, Canada, Revenue ($ mn) by Segment, Forecast, 2007-2012; Figure 40: Instruments, Canada, Company Share (%), 2007; Figure 41: Microbiology Test Reagents, Canada, Revenue ($ mn) by Segment, Forecast, 2007-2012; Figure 42: Bacteriology Test Reagents, Canada, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007; Figure 43: Bacteriology Test Reagents, Canada, Revenues ($ mn) by Sub-Segment, Forecast,, 2007-2012; Figure 44: Microbiology Test Reagents, Canada, Company Share (%), 2007; Figure 45: Self Testing, Canada, Revenue ($ mn) by Segment, Historic, 2000-2007; Figure 46: Self Testing, Canada, Revenue ($ mn) by Segment, Forecast, 2007-2012; Figure 47: Self Testing, Canada, Company Share (%), 2007; Figure 48: F. Hoffmann-La Roche Ltd Value Chain Analysis; Figure 49: Beckman Coulter, Inc. Value Chain Analysis; Figure 50: Abbott Laboratories Value Chain Analysis; Figure 51: Siemens Medical Solutions Value Chain Analysis; Figure 52: Biomerieux Sa Value Chain Analysis; Figure 53: Global Markets Direct Methodology

	Research Index \| Publishers \| My Account \| Contact Us \| About MindBranch
	Welcome Guest (Login/Register) \| 0 items